• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV 与肠道微生物群,狼狈为奸:打破恶性循环,发掘新的治疗靶点。

HIV and the gut microbiota, partners in crime: breaking the vicious cycle to unearth new therapeutic targets.

机构信息

Chronic Viral Illness Service, McGill University Health Centre, 3650 Saint Urbain, Montreal, QC, Canada H2X 2P4 ; Research Institute, McGill University Health Centre, Montreal, QC, Canada H3H 2R9.

Chronic Viral Illness Service, McGill University Health Centre, 3650 Saint Urbain, Montreal, QC, Canada H2X 2P4 ; Research Institute, McGill University Health Centre, Montreal, QC, Canada H3H 2R9 ; Division of Hematology, McGill University Health Centre, 687 Pine Avenue West, Montreal, QC, Canada H3A 1A1.

出版信息

J Immunol Res. 2015;2015:614127. doi: 10.1155/2015/614127. Epub 2015 Feb 22.

DOI:10.1155/2015/614127
PMID:25759844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4352503/
Abstract

The gut microbiota plays a key role in health and immune system education and surveillance. The delicate balance between microbial growth and containment is controlled by the immune system. However, this balance is disrupted in cases of chronic viral infections such as HIV. This virus is capable of drastically altering the immune system and gastrointestinal environment leading to significant changes to the gut microbiota and mucosal permeability resulting in microbial translocation from the gut into the peripheral blood. The changes made locally in the gut have far-reaching consequences on the other organs of the body starting in the liver, where microbes and their products are normally filtered out, and extending to the blood and even brain. Microbial translocation and their downstream effects such as increased indolamine 2,3-dioxygenase (IDO) enzyme expression and activity create a self-sustaining feedback loop which enhances HIV disease progression and constitute a vicious cycle of inflammation and immune activation combining viral and bacterial factors. Understanding this self-perpetuating cycle could be a key element in developing new therapies aimed at the gut microbiota and its fallout after infection.

摘要

肠道微生物群在健康和免疫系统的教育和监测中起着关键作用。微生物生长和控制之间的微妙平衡由免疫系统控制。然而,在慢性病毒感染(如 HIV)的情况下,这种平衡会被打破。这种病毒能够极大地改变免疫系统和胃肠道环境,导致肠道微生物群和黏膜通透性发生显著变化,从而导致微生物从肠道转移到外周血液中。肠道内的局部变化对身体的其他器官产生深远的影响,从肝脏开始,微生物及其产物通常在肝脏中被过滤掉,然后延伸到血液,甚至大脑。微生物易位及其下游效应,如增加吲哚胺 2,3-双加氧酶(IDO)酶的表达和活性,形成一个自我维持的反馈环,增强 HIV 疾病的进展,并构成炎症和免疫激活的恶性循环,结合病毒和细菌因素。了解这种自我维持的循环可能是开发针对感染后肠道微生物群及其后果的新疗法的关键因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f59/4352503/55daf6336382/JIR2015-614127.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f59/4352503/55daf6336382/JIR2015-614127.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f59/4352503/55daf6336382/JIR2015-614127.001.jpg

相似文献

1
HIV and the gut microbiota, partners in crime: breaking the vicious cycle to unearth new therapeutic targets.HIV 与肠道微生物群,狼狈为奸:打破恶性循环,发掘新的治疗靶点。
J Immunol Res. 2015;2015:614127. doi: 10.1155/2015/614127. Epub 2015 Feb 22.
2
Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infection.肠道屏障结构、黏膜免疫与肠道微生物群在HIV感染的发病机制及治疗中的作用
AIDS Res Ther. 2016 Apr 11;13:19. doi: 10.1186/s12981-016-0103-1. eCollection 2016.
3
[Gut microbiota and development of the immune system].[肠道微生物群与免疫系统的发育]
Med Sci (Paris). 2016 Nov;32(11):961-967. doi: 10.1051/medsci/20163211011. Epub 2016 Dec 23.
4
Clinical Relevance of Kynurenine Pathway in HIV/AIDS: An Immune Checkpoint at the Crossroads of Metabolism and Inflammation.犬尿氨酸途径在HIV/AIDS中的临床相关性:代谢与炎症交叉点上的一个免疫检查点
AIDS Rev. 2015 Apr-Jun;17(2):96-106.
5
Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity.人类免疫缺陷病毒与丙型肝炎病毒合并感染患者的肠道上皮屏障功能障碍:对固有免疫和获得性免疫的影响
World J Gastroenterol. 2016 Jan 28;22(4):1433-48. doi: 10.3748/wjg.v22.i4.1433.
6
[Gut microbiota and immune crosstalk in metabolic disease].[代谢性疾病中的肠道微生物群与免疫相互作用]
Biol Aujourdhui. 2017;211(1):1-18. doi: 10.1051/jbio/2017008. Epub 2017 Jul 6.
7
Inside Out: HIV, the Gut Microbiome, and the Mucosal Immune System.由内而外:HIV、肠道微生物群与黏膜免疫系统
J Immunol. 2017 Jan 15;198(2):605-614. doi: 10.4049/jimmunol.1601355.
8
Metabolism at the centre of the host-microbe relationship.宿主-微生物关系的核心是代谢。
Clin Exp Immunol. 2019 Aug;197(2):193-204. doi: 10.1111/cei.13329. Epub 2019 Jun 7.
9
The role of the adaptive immune system in regulation of gut microbiota.适应性免疫系统在肠道微生物群调节中的作用。
Immunol Rev. 2014 Jul;260(1):67-75. doi: 10.1111/imr.12185.
10
Microbiome of HIV-infected people.HIV感染者的微生物组。
Microb Pathog. 2017 May;106:85-93. doi: 10.1016/j.micpath.2016.05.015. Epub 2016 May 20.

引用本文的文献

1
Intestinal Microbiota and Aging in People with HIV-What We Know and What We Don't.HIV感染者的肠道微生物群与衰老——我们所知与未知的
Curr HIV/AIDS Rep. 2024 Dec 12;22(1):9. doi: 10.1007/s11904-024-00717-w.
2
Nuclear Factor Kappa B p65: A Possible Biomarker for Persistent Inflammation in HIV-1 Infection?核因子κB p65:HIV-1感染中持续性炎症的一种可能生物标志物?
Cureus. 2024 Oct 12;16(10):e71308. doi: 10.7759/cureus.71308. eCollection 2024 Oct.
3
Soluble markers of viral rebound and post-treatment HIV control.病毒反弹和治疗后HIV控制的可溶性标志物。

本文引用的文献

1
HIV-induced alteration in gut microbiota: driving factors, consequences, and effects of antiretroviral therapy.HIV 诱导的肠道菌群改变:驱动因素、后果和抗逆转录病毒治疗的影响。
Gut Microbes. 2014 Jul 1;5(4):562-70. doi: 10.4161/gmic.32132. Epub 2014 Jul 31.
2
Intestinal barrier dysfunction in HIV infection: pathophysiology, clinical implications and potential therapies.HIV 感染相关的肠屏障功能障碍:病理生理学、临床意义和潜在治疗方法。
Infection. 2014 Dec;42(6):951-9. doi: 10.1007/s15010-014-0666-5. Epub 2014 Jul 29.
3
Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection.
Curr Opin HIV AIDS. 2025 Jan 1;20(1):61-69. doi: 10.1097/COH.0000000000000889. Epub 2024 Sep 25.
4
Pathophysiology and Clinical Management of Dyslipidemia in People Living with HIV: Sailing through Rough Seas.HIV感染者血脂异常的病理生理学与临床管理:穿越惊涛骇浪
Life (Basel). 2024 Mar 28;14(4):449. doi: 10.3390/life14040449.
5
Effects of statins beyond lipid-lowering agents in ART-treated HIV infection.他汀类药物在接受抗逆转录病毒治疗的HIV感染中除降脂作用之外的其他作用。
Front Immunol. 2024 Apr 9;15:1339338. doi: 10.3389/fimmu.2024.1339338. eCollection 2024.
6
Distinct intestinal microbial signatures linked to accelerated systemic and intestinal biological aging.与加速的全身和肠道生物衰老相关的独特肠道微生物特征。
Microbiome. 2024 Feb 22;12(1):31. doi: 10.1186/s40168-024-01758-4.
7
Distinct Lipidomic Signatures in People Living With HIV: Combined Analysis of ACTG 5260s and MACS/WIHS.HIV 感染者的独特脂质组学特征:ACTG 5260s 和 MACS/WIHS 的联合分析。
J Clin Endocrinol Metab. 2022 Jan 1;107(1):119-135. doi: 10.1210/clinem/dgab663.
8
Gut Microbiome Changes Associated with Epithelial Barrier Damage and Systemic Inflammation during Antiretroviral Therapy of Chronic SIV Infection.慢性 SIV 感染的抗逆转录病毒治疗期间,与上皮屏障损伤和全身炎症相关的肠道微生物组变化。
Viruses. 2021 Aug 8;13(8):1567. doi: 10.3390/v13081567.
9
miR-125b-5p inhibits cell proliferation by targeting ASCT2 and regulating the PI3K/AKT/mTOR pathway in an LPS-induced intestinal mucosa cell injury model.在脂多糖诱导的肠黏膜细胞损伤模型中,miR-125b-5p通过靶向ASCT2并调节PI3K/AKT/mTOR信号通路来抑制细胞增殖。
Exp Ther Med. 2021 Aug;22(2):838. doi: 10.3892/etm.2021.10270. Epub 2021 Jun 6.
10
Paraprobiotics and Postbiotics of Probiotic , Their Positive Effects on the Host and Action Mechanisms: A Review.益生菌的副益生菌和后生元及其对宿主的积极作用和作用机制:综述
Front Nutr. 2020 Oct 22;7:570344. doi: 10.3389/fnut.2020.570344. eCollection 2020.
可溶性CD40配体(sCD40L,sCD154)在HIV感染中通过调节性T细胞扩增发挥免疫抑制作用。
Clin Exp Immunol. 2014 Oct;178(1):102-11. doi: 10.1111/cei.12396.
4
Intestinal barrier: A gentlemen's agreement between microbiota and immunity.肠道屏障:微生物群与免疫系统之间的君子协定。
World J Gastrointest Pathophysiol. 2014 Feb 15;5(1):18-32. doi: 10.4291/wjgp.v5.i1.18.
5
Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infection.司维拉姆不会降低未接受治疗的HIV感染者的脂多糖或可溶性CD14水平,但会降低可溶性组织因子、低密度脂蛋白(LDL)胆固醇和氧化LDL胆固醇水平。
J Infect Dis. 2014 Nov 15;210(10):1549-54. doi: 10.1093/infdis/jiu305. Epub 2014 May 26.
6
The mycobiota: interactions between commensal fungi and the host immune system.真菌群:共生真菌与宿主免疫系统的相互作用。
Nat Rev Immunol. 2014 Jun;14(6):405-16. doi: 10.1038/nri3684.
7
The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota.肝脏可能充当防火墙,介导宿主与其肠道共生微生物群之间的共生关系。
Sci Transl Med. 2014 May 21;6(237):237ra66. doi: 10.1126/scitranslmed.3008618.
8
Early microbial translocation blockade reduces SIV-mediated inflammation and viral replication.早期微生物易位阻断可减少 SIV 介导的炎症和病毒复制。
J Clin Invest. 2014 Jun;124(6):2802-6. doi: 10.1172/JCI75090. Epub 2014 May 16.
9
Gut microbiome and anticancer immune response: really hot Sh*t!肠道微生物群与抗癌免疫反应:极其热门的话题!
Cell Death Differ. 2015 Feb;22(2):199-214. doi: 10.1038/cdd.2014.56. Epub 2014 May 16.
10
Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study.在 SMART 研究中,HIV/HCV 合并感染患者的炎症、凝血和微生物易位的生物标志物。
J Clin Virol. 2014 Jul;60(3):295-300. doi: 10.1016/j.jcv.2014.03.017. Epub 2014 Apr 8.